Drug General Information
Drug ID
D01XRM
Former ID
DAP001489
Drug Name
Levetriacetam
Drug Type
Small molecular drug
Indication Fibromyalgia [ICD9: 729.1; ICD10:M79.7] Approved [536647]
Company
UCB Pharmaceuticals Inc
Structure
Download
2D MOL

3D MOL

Formula
C8H14N2O2
Canonical SMILES
CCC(C(=O)N)N1CCCC1=O
InChI
1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1
InChIKey
HPHUVLMMVZITSG-LURJTMIESA-N
CAS Number
CAS 102767-28-2
PubChem Compound ID
PubChem Substance ID
SuperDrug ATC ID
N03AX14
SuperDrug CAS ID
cas=102767282
Target and Pathway
Target(s) 5-hydroxytryptamine receptor 3A Target Info Antagonist [536647]
KEGG Pathway Serotonergic synapse
NetPath Pathway IL2 Signaling Pathway
PANTHER Pathway 5HT3 type receptor mediated signaling pathway
Reactome Ligand-gated ion channel transport
WikiPathways SIDS Susceptibility Pathways
Iron uptake and transport
References
Ref 536647Emerging therapies for fibromyalgia. Expert Opin Emerg Drugs. 2008 Mar;13(1):53-62.
Ref 536647Emerging therapies for fibromyalgia. Expert Opin Emerg Drugs. 2008 Mar;13(1):53-62.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.